Literature DB >> 3044717

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation.

E A Pariente1, A Goudeau, F Dubois, C Degott, E Gluckman, A Devergie, C Brechot, C Schenmetzler, J Bernuau.   

Abstract

A case of hepatitis B reactivation following bone-marrow transplantation for leukemia in a previously healthy HBsAg carrier is reported. A number of changes in HBV serum markers were contemporary to the acute episode. All of them (increase of HBsAg concentration, conversion from anti-HBe to HBeAg, appearance of anti-HBc IgM and of serum HBV-DNA) were suggestive of a "switching-on" of viral replication. Institution of corticosteroid treatment at the onset of the acute phase did not prevent the fatal outcome.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3044717     DOI： 10.1007/BF01535798

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  15 in total

1.  Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.

Authors:  J Rakela; A G Redeker; B Weliky
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

2.  Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy.

Authors:  J R Wands
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

3.  Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.

Authors:  R M Galbraith; A L Eddleston; R Williams; A J Zuckerman
Journal:  Lancet       Date:  1975-09-20       Impact factor: 79.321

4.  Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.

Authors:  J H Hoofnagle; G M Dusheiko; D F Schafer; E A Jones; K C Micetich; R C Young; J Costa
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

5.  Spontaneous reactivation of chronic hepatitis B virus infection.

Authors:  G L Davis; J H Hoofnagle; J G Waggoner
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

6.  Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis.

Authors:  R P Perrillo; C R Campbell; G E Sanders; F G Regenstein; C J Bodicky
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

7.  Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Authors:  G B McDonald; P Sharma; D E Matthews; H M Shulman; E D Thomas
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

8.  Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis.

Authors:  D C Snover; S A Weisdorf; N K Ramsay; P McGlave; J H Kersey
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

9.  Reactivation of chronic type B hepatitis presenting as acute viral hepatitis.

Authors:  G L Davis; J H Hoofnagle
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

10.  Reactivation of hepatitis b after transplantation operations.

Authors:  J Nagington
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321
View more
  9 in total

1.  Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Authors:  M Yoshiba; K Sekiyama; F Sugata; H Okamoto; K Yamamoto; S Yotsumoto
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

2.  Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.

Authors:  Wen-Pin Su; Chi-Chung Wen; Chao-A Hsiung; Ih-Jen Su; Ann-Lii Cheng; Ming-Chih Chang; Chao-Jung Tsao; Woei-Yao Kao; Wu-Ching Uen; Chiun Hsu; Chih-Hung Hsu; Yen-Shen Lu; Hwei-Fan Tien; Tsu-Yi Chao; Li-Tzong Chen; Jacqueline Whang-Peng; Pei-Jer Chen
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

3.  Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease.

Authors:  C Ustün; M Ozcan; G Gürman; M Cakir; S Erekul; G Akyol; M Arat; H Celebi; R Idlman; O Ilhan; T Demirer; M Beksac; H Koc
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  Hepatitis B reactivation after chemotherapy: two decades of clinical research.

Authors:  George K K Lau
Journal:  Hepatol Int       Date:  2008-03-05       Impact factor: 6.047

5.  Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.

Authors:  S Kubo; S Nishiguchi; H Hamba; K Hirohashi; H Tanaka; T Shuto; H Kinoshita; T Kuroki
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.

Authors:  M Yoshiba; K Sekiyama; K Inoue; R Fujita
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

7.  Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.

Authors:  Y Ilan; A Nagler; D Shouval; A Ackerstein; R Or; J Kapelushnik; R Adler; S Slavin
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

8.  Fulminant hepatitis following bone marrow transplantation in hepatitis B virus carrier siblings.

Authors:  F Omata; F Ueno; Y Kushibiki; H Takahashi
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

Review 9.  Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management.

Authors:  Alessandra Zannella; Massimo Marignani; Paola Begini
Journal:  Viruses       Date:  2019-09-14       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.